Submit Deal

MONOGRAPH CAPITAL

Summary

Monograph Capital is a life sciences venture firm.

Deals Overview

Total Deals6

Valued Deals6

Total Value£ 733 M

Avg. Deal Size£ 122 M

Market Context

Senior Management

Fred Cohen
Chairman
Tim Funnell
Partner

Sort

04 Aug 2022|United Kingdom|Biotechnology

Target: MIROBIO

Bidder: GILEAD SCIENCES

11 Service Providers

6 Target | 5 Bidder

42 Dealmakers

27 Target | 15 Bidder

£ 333 M

Value

01 Nov 2022|United States|Biotechnology

Target: HUMAN IMMUNOLOGY BIOSCIENCES

Bidder: ARCH VENTURE PARTNERS

5 Service Providers

1 Target | 4 Bidder

5 Dealmakers

1 Target | 4 Bidder

£ 104 M

Value

01 May 2023|Canada|Software

Target: ODAIA INTELLIGENCE

Bidder: THRESHOLD VENTURES

4 Service Providers

2 Target | 2 Bidder

4 Dealmakers

1 Target | 3 Bidder

£ 19 M

Value

20 Dec 2023|United States|Pharmaceuticals

Target: SUDO BIOSCIENCES

Bidder: ENAVATE SCIENCES

7 Service Providers

2 Target | 5 Bidder

7 Dealmakers

2 Target | 5 Bidder

£ 123 M

Value

17 Mar 2025|United Kingdom|Biotechnology

Target: MAXION THERAPEUTICS

Bidder: GENERAL CATALYST PARTNERS

4 Service Providers

2 Target | 2 Bidder

29 Dealmakers

4 Target | 25 Bidder

£ 55 M

Value

10 Jan 2025|United States|Biotechnology

Target: OURO MEDICINES

Bidder: GSK PLC

10 Service Providers

2 Target | 8 Bidder

14 Dealmakers

6 Target | 9 Bidder

£ 97 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy